Cleared Traditional

K193268 - APrioCore Plus

K193268 is the FDA 510(k) clearance for APrioCore Plus by Apriomed AB. It is a Class 2 General & Plastic Surgery device (product code KNW) cleared through the Traditional 510(k) pathway after a 93-day FDA review.

K193268 · Apriomed AB · General & Plastic Surgery device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Feb 2020
Decision
93d
Days
Class 2
Risk

K193268 is an FDA 510(k) clearance for the APrioCore Plus. Classified as Instrument, Biopsy (product code KNW), Class II - Special Controls.

Submitted by Apriomed AB (Uppsala, SE). The FDA issued a Cleared decision on February 27, 2020 after a review of 93 days - within the typical 510(k) review window.

This device falls under the General & Plastic Surgery FDA review panel, regulated under 21 CFR 876.1075 - the FDA general and plastic surgery device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the General & Plastic Surgery review framework, consistent with the majority of Class II 510(k) submissions.

View all Apriomed AB devices

Submission Details

510(k) Number K193268 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received November 26, 2019
Decision Date February 27, 2020
Days to Decision 93 days
Submission Type Traditional
Review Panel General & Plastic Surgery (SU)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
22d faster than avg
Panel avg: 115d · This submission: 93d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code KNW Instrument, Biopsy
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 876.1075
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General & Plastic Surgery devices follow this clearance model.

Regulatory Peers - KNW Instrument, Biopsy

All 160
Devices cleared under the same product code (KNW) and FDA review panel - the closest regulatory comparables to K193268.
MED-I Bone Marrow Aspiration Needle, MED-S Bone Marrow Aspiration Needle, MED-L Bone Marrow Biopsy and Aspiration System, MED-B Bone Marrow Biopsy System, MED-J Bone Marrow Biopsy and Aspiration System
K192099 · Medax Srl Unipersonale · Apr 2020
Medone Ultra, Medextra
K192101 · Medax Srl Unipersonale · Apr 2020
CytoCore
K200278 · Praxis Medical, LLC · Mar 2020
EleVation Breast Biopsy Driver, EleVation Breast Biopsy Probe - 10G, EleVation Breast Biopsy Probe - 14G
K192948 · Bard Peripheral Vascular, Inc. · Nov 2019
Remington Medical, Inc. Automatic Cutting Needle (NAC)
K191315 · Remington Medical, Inc. · Jul 2019
J-Type Marrow Biopsy Needle,T-Type Marrow Biopsy Needle,Tweezer Bone Marrow Biopsy Needle,
K190177 · Ranfac Corporation · Jun 2019